Literature DB >> 7438464

Studies of circulating parathyroid hormone in man using a homologous amino-terminal specific immunoradiometric assay.

S E Papapoulos, R M Manning, G N Hendy, I G Lewin, J L O'Riordan.   

Abstract

Circulating immunoreactive parathyroid hormone (PTH) was measured by a homologous, amino-terminal, specific, immunoradiometric assay in man. In forty-two healthy subjects the concentrations ranged between < 40 pg/ml and 120 pg/ml. No hormone could be detected in the sera of eleven patients with hypoparathyroidism, but the concentrations were clearly elevated in six patients with pseudohypoparathyroidism (range 190-1120 pg/ml). In thirty-five patients with primary hyperparathyroidism the mean (+/- SEM) concentration was 283.4 +/- 42.4 pg/ml (range 100-1350 pg/ml). A significant positive correlation was demonstrated between immunoassayable hormone and serum calcium concentrations in these patients. In nine patients PTH concentrations were measured before and after parathyroidectomy. In all of them they were elevated pre-operatively but fell to the normal range after parathyroidectomy. The disappearance of exogenously administered synthetic human PTH (1-34) from the circulation of two normal subjects was rapid with an apparent plasma half-disappearance time (t1/2) between 2 and 3 min; the metabolic clearance rate was 12.9 and 9.0 ml. kg-1 . min-1 respectively. Similarly, the disappearance of endogenous, amino-terminal, immunoreactive PTH from the circulation of two patients with primary hyperparathyroidism after parathyroidectomy was rapid; the apparent t1/2 was approximately 3 min. Homologous amino-terminal specific immunoassays for PTH can thus be useful for the study of both the acute, and chronic, changes of circulating hormone in man and represent an improvement over heterologous unselected assay systems.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7438464     DOI: 10.1111/j.1365-2265.1980.tb01023.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  12 in total

1.  Intermittent hypercalcaemia and vitamin D sensitivity in Hodgkin's disease.

Authors:  R Karmali; S Barker; M Hewison; L Fraher; D R Katz; J L O'Riordan
Journal:  Postgrad Med J       Date:  1990-09       Impact factor: 2.401

2.  A case of resolving idiopathic hypoparathyroidism.

Authors:  L Ostlere; J Reeve
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

Review 3.  Calcium-sensing receptor 20 years later.

Authors:  Tariq I Alfadda; Ahmad M A Saleh; Pascal Houillier; John P Geibel
Journal:  Am J Physiol Cell Physiol       Date:  2014-05-28       Impact factor: 4.249

4.  Prolonged fever associated with primary hyperparathyroidism.

Authors:  J Ricci; J Vlasschaert; I E Salit
Journal:  Can Med Assoc J       Date:  1984-09-01       Impact factor: 8.262

5.  Spontaneous remission of secondary hyperparathyroidism in patient receiving regular dialysis.

Authors:  R Ahmad; N Raichura; H J Goldsmith
Journal:  Br Med J (Clin Res Ed)       Date:  1982-02-13

6.  Vitamin D-dependent rickets type II: extreme end organ resistance to 1,25-dihydroxy vitamin D3 in a patient without alopecia.

Authors:  L J Fraher; R Karmali; F R Hinde; G N Hendy; H Jani; L Nicholson; D Grant; J L O'Riordan
Journal:  Eur J Pediatr       Date:  1986-10       Impact factor: 3.183

7.  Neonatal hyperparathyroidism.

Authors:  C A Dezateux; J C Hyde; H M Hoey; J L O'Riordan; L Spitz; G W Taylor; D B Grant
Journal:  Eur J Pediatr       Date:  1984-06       Impact factor: 3.183

8.  Cytochemical bioassay of parathyroid hormone in maternal and cord blood.

Authors:  J Allgrove; S Adami; R M Manning; J L O'Riordan
Journal:  Arch Dis Child       Date:  1985-02       Impact factor: 3.791

9.  Suppression of secondary hyperparathyroidism in uraemia: acute and chronic studies.

Authors:  N Muirhead; G R Catto; N Edward; S Adami; R M Manning; J L O'Riordan
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-21

10.  Autotransplantation of human parathyroid glands.

Authors:  P J Billings; E Milroy
Journal:  Ann R Coll Surg Engl       Date:  1986-01       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.